Keyword: Elsevier

The well-known dangers of diagnostic error are now being amplified by the growing trend that’s seeing patients and clinicians opt for free websites or other synoptic content over more thorough, vetted information.

Join us for this webinar as we bring together a panel of industry experts to discuss the changing landscape of biosimilar development and how it will affect pricing in the future.